The Journal of Allergy and Clinical Immunology
Volume 127, Issue 5 , Pages 1110-1118, May 2011

Contrasting pathogenesis of atopic dermatitis and psoriasis—Part I: Clinical and pathologic concepts

  • Emma Guttman-Yassky, MD, PhD

      Affiliations

    • Laboratory for Investigative Dermatology, the Rockefeller University, New York, NY
    • Department of Dermatology, Weill-Cornell Medical College, New York, NY
    • Corresponding Author InformationReprint requests: Emma Guttman-Yassky, MD, PhD, Laboratory for Investigative Dermatology, The Rockefeller University, 1230 York Ave, New York, NY 10065.
  • ,
  • Kristine E. Nograles, MD, MSc

      Affiliations

    • Laboratory for Investigative Dermatology, the Rockefeller University, New York, NY
  • ,
  • James G. Krueger, MD, PhD

      Affiliations

    • Laboratory for Investigative Dermatology, the Rockefeller University, New York, NY

Received 14 November 2010; received in revised form 27 December 2010; accepted 5 January 2011. published online 09 March 2011.

Atopic dermatitis and psoriasis are 2 of the most common inflammatory skin diseases. They are similar in that they are complex inherited diseases involving genes that encode immune components and structural proteins that regulate differentiation of epidermal cells. Each disease is characterized by proliferation of epidermal keratinocytes and abnormal cornification or terminal differentiation in the epidermis; skin lesions contain immune infiltrates of T cells, dendritic cells, and other types of leukocytes. We review similarities between the diseases and differences in epidermal barrier defects and immune cells. We also propose mechanisms of pathogenesis based on differences in the balance of immune cell subsets that could cause the phenotypes that distinguish these diseases. The first part of this 2-part review focuses on the clinical and pathologic features of the diseases; the second part discusses differences in immune cell subsets between atopic dermatitis and psoriasis and recent therapeutic strategies.

Key words: Atopic dermatitis, psoriasis, pathogenesis, therapy

Abbreviations used: AD, Atopic dermatitis, CE, Cornified envelope, DC, Dendritic cell, EDC, Epidermal differentiation complex gene, FLG, Filaggrin gene, LCE, Late cornified envelope gene, SC, Stratum corneum, Treg, Regulatory T

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Disclosure of potential conflict of interest: E. Guttman-Yassky and K. E. Nograles have declared that they have no conflict of interest. J. G. Krueger has consulted for Amgen, Anacor Pharmaceuticals, Centocor, Gateway Pharmaceuticals, Idera Pharmaceuticals, and Pfizer; has performed investigations for Boehringer Ingelheim, Eli Lilly, and Merck; has served on an advisory board for Janssen; and has received research support (through Rockefeller University) from Amgen, Centocor, Merck, and Eli Lilly.

PII: S0091-6749(11)00183-7

doi:10.1016/j.jaci.2011.01.053

The Journal of Allergy and Clinical Immunology
Volume 127, Issue 5 , Pages 1110-1118, May 2011